Patients with Chronic Inflammatory Rheumatic diseases (CIRD) are at increased risk of
cardiovascular disease (CVD), ascribed not only to classical risk factors, but also to the …

There is solid epidemiologic evidence linking psoriasis and psoriatic arthritis (PsA) to
cardiovascular risk factors and an increased risk of developing cardiovascular disease …

Aortic stiffness (AoS) is a maladaptive response to hemodynamic stress and both modifiable
and non-modifiable risk factors, and elevated AoS increases afterload for the heart. AoS is a …

Psoriasis frequency ranges from 1 to 3% in white population, and arthritis occurs in 10–40%
of psoriasis patients, representing a relevant health issue. Psoriatic arthritis (PsA) is an …

Objectives Non-alcoholic fatty liver disease (NAFLD), potentially evolving into liver fibrosis
(LF), is frequent in psoriasis (PsO), but data in psoriatic arthritis (PsA) are lacking. Our study …

Background and objective Cardiovascular diseases (CVD) are the leading causes of death
in chronic inflammatory rheumatic diseases and are not solely explained by the increased …

The increased cardiovascular (CV) risk among patients with autoimmune rheumatic
diseases, such as arthritides and connective tissue diseases, has been extensively …

Psoriatic arthritis (PsA) is characterized by chronic inflammation of peripheral joints and
axial skeleton, associated with a strong genetic background. Clinics include enthesitis or …

Objective The present study tested the hypothesis that arterial stiffness will be elevated
across overall and specific inflammatory disorders compared with an inflammation-free …

Background: Psoriatic arthritis is a chronic inflammatory arthropathy that affects 14%-30% of
patients with skin and/or nail psoriasis, leading to severe physical limitations and disability. It …